EUVIMEDEUVIMED entdecken
Crossref

TLR9 activation induces immunosuppression and tumorigenesis via PARP1/PD-L1 signaling pathway in oral squamous cell carcinoma

Liwei Ma, Niuyu Qin, Wendong Wan, Saiwen Song, Siqi Hua, Canhua Jiang, Ning Li, Long Huang, Xing Gao iD

American Journal of Physiology-Cell Physiology · 2024

DOI: 10.1152/ajpcell.00061.2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2024. Verfasst von Liwei Ma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Medicine, Center of Stomatology, Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Fellowship of China Postdoctoral Science Foundation, Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this research, we took PARP1 as the key target to explore its regulatory effect on oral squamous cell carcinoma (OSCC). The key molecular mechanisms involved in its upstream and downstream regulation were elucidated in OSCC cell lines in vitro and tumor-bearing mice in vivo, combined with clinical OSCC tissues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellMouth NeoplasmsHead and Neck NeoplasmsHumansAnimalsMiceSquamous Cell Carcinoma of Head and NeckB7-H1 AntigenToll-Like Receptor 9Signal TransductionCarcinogenesisCell Transformation, NeoplasticImmunosuppression TherapyCell Line, TumorCell ProliferationPoly (ADP-Ribose) Polymerase-1

Stichwörter der Autor:innen

OSCCPARP1/PD-L1 signaling pathwaySTAT3TLR9immunosuppression

Substanzen

B7-H1 AntigenToll-Like Receptor 9TLR9 protein, humanPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1

Autor:innen und Institutionen

  • Department of Oral Medicine, Center of Stomatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Center of Oral and Maxillofacial Cancer (COMAC), Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Institute of Oral Cancer and Precancerous Lesions, Central South University, Changsha, Hunan, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Oral and Maxillofacial Surgery, Center of Stomatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, Hunan, China.

ORCID-Profile: Xing Gao

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • Fellowship of China Postdoctoral Science Foundation
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Ma, L., Qin, N., Wan, W., Song, S., Hua, S., Jiang, C., Li, N., Huang, L., & Gao, X. (2024). TLR9 activation induces immunosuppression and tumorigenesis via PARP1/PD-L1 signaling pathway in oral squamous cell carcinoma. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00061.2023

Vancouver

Ma L, Qin N, Wan W, Song S, Hua S, Jiang C, et al. TLR9 activation induces immunosuppression and tumorigenesis via PARP1/PD-L1 signaling pathway in oral squamous cell carcinoma. American Journal of Physiology-Cell Physiology. 2024. doi:10.1152/ajpcell.00061.2023

BibTeX
@article{Ma2024,
  author = {Ma, Liwei and Qin, Niuyu and Wan, Wendong and Song, Saiwen and Hua, Siqi and Jiang, Canhua and Li, Ning and Huang, Long and Gao, Xing},
  title = {TLR9 activation induces immunosuppression and tumorigenesis via PARP1/PD-L1 signaling pathway in oral squamous cell carcinoma},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2024},
  doi = {10.1152/ajpcell.00061.2023}
}
Kostenlos starten →